Bavarian Nordic Seeks Partner After RSV Jab Generates Glowing Phase II Data

Danish Biotech CEO Says Commercializing MVA-BN RSV Is Key Objective Now

Candidate Vaccine MVA-BN RSV Contains Five Different Antigens of RSV virus • Source: Alamy

More from Clinical Trials

More from R&D